Charleston County Public Library

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Liposomal factor VIII as an efficient pharmaceutical system for the treatment of hemophilia.

Authors : Karimi, Maryam; Rezayat, Seyed Mahdi; Mortazavi, Seyed Alireza

Subjects: HEMOPHILIA treatment; BLOOD coagulation factor VIII; PHASE transitions

Source: Iranian Journal of Basic Medical Sciences; Jun2024, Vol. 27 Issue 6, p747-754, 8p

Record details

Read More Add to Saved list

Academic Journal

Hybrid human‐porcine factor VIII proteins partially escape the inhibitory effects of anti‐factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.

Authors : Mizumachi, Kuniyoshi; Nakajima, Yuto; Shimonishi, Naruto

Subjects: BLOOD coagulation factor VIII; BLOOD coagulation factor VIII antibodies; PROTEINS

Source: Haemophilia; Jan2024, Vol. 30 Issue 1, p140-150, 11p

Record details

Read More Add to Saved list

Academic Journal

Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis.

Authors : Srichumpuang, Chonlatis; Rakmanotham, Arunothai; Moonla, Chatphatai

Subjects: BLOOD coagulation factor VIII; HEMOPHILIACS; PHYSICAL activity

Source: Orphanet Journal of Rare Diseases; 3/26/2024, Vol. 19 Issue 1, p1-9, 9p

Record details

Read More Add to Saved list

Academic Journal

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.

Authors : Oomen, Ilja; Verhagen, Marieke; Miranda, Mariarosaria

Subjects: HEMOPHILIACS; BLOOD coagulation factor VIII antibodies; IMMUNOGLOBULIN ANIJMEGEN (Netherlands)NATIONAL Basketball Association

Source: Frontiers in Immunology; 2024, p1-12, 12p

Record details

Read More Add to Saved list

Academic Journal

Interim analyses of the multinational real‐world prospective cohort HEM‐POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.

Authors : Reding, Mark T.; Álvarez‐Román, María Teresa; Castaman, Giancarlo

Subjects: HEMOPHILIACS; BLOOD coagulation factor VIII antibodies; ADVERSE health care events

Source: European Journal of Haematology; Feb2024, Vol. 112 Issue 2, p286-295, 10p

Record details

Read More Add to Saved list

Academic Journal

Management and Outcomes of Invasive Procedures in Individuals with Hemophilia A on Emicizumab Prophylaxis: A Single Center Experience.

Authors : Rener, Karla; Doma, Saša Anžej; Fink, Martina

Subjects: TOTAL ankle replacement; HEMOPHILIA; BLOOD coagulation factor VIII antibodies

Source: Hematology Reports; Dec2023, Vol. 15 Issue 4, p597-607, 11p

Record details

Read More Add to Saved list

Academic Journal

Clinical efficacy of simoctocog alfa versus extended half-life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching-adjusted indirect comparison method.

Authors : Kessler, Craig M.; Corrales-Medina, Fernando F.; Mannucci, Pier Mannuccio

Subjects: HEMOPHILIACS; PREVENTIVE medicine; BLOOD coagulation factor VIII

Source: European Journal of Haematology; Nov2023, Vol. 111 Issue 5, p757-767, 11p

Record details

Read More Add to Saved list

Academic Journal

A frameshift deletion in F8 associated with hemophilia A in Labrador Retriever dogs.

Authors : Hytönen, Marjo K.; Viitanen, Sanna; Hundi, Sruthi

Subjects: LABRADOR retriever; HEMOPHILIA; FRAMESHIFT mutation

Source: Animal Genetics; Oct2023, Vol. 54 Issue 5, p606-612, 7p

Record details

Read More Add to Saved list

Academic Journal

A male case of dermatofibrosarcoma protuberans in the breast presenting as gynecomastia.

Authors : Ćirilović, Viktorija Vučaj; Vuković, Miloš; Boban, Jasmina

Subjects: GYNECOMASTIA; BLOOD coagulation factor VIII; DIAGNOSIS

Source: Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia. Oct2021, Vol. 78 Issue 10, p1108-1112. 5p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases.

Authors : Lu, Xinyue; Zhang, Miaomiao; Li, Ge

Subjects: GENETIC disorders; THERAPEUTICS; CRISPRS

Source: International Journal of Molecular Sciences; Sep2023, Vol. 24 Issue 17, p13202, 19p

Record details

Read More Add to Saved list

menu

Search Results

Your Filters

Liposomal factor VIII as an efficient pharmaceutical system for the treatment of hemophilia.

Hybrid human‐porcine factor VIII proteins partially escape the inhibitory effects of anti‐factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.

Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis.

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.

Interim analyses of the multinational real‐world prospective cohort HEM‐POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.

Management and Outcomes of Invasive Procedures in Individuals with Hemophilia A on Emicizumab Prophylaxis: A Single Center Experience.

Clinical efficacy of simoctocog alfa versus extended half-life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching-adjusted indirect comparison method.

A frameshift deletion in F8 associated with hemophilia A in Labrador Retriever dogs.

A male case of dermatofibrosarcoma protuberans in the breast presenting as gynecomastia.

Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases.

Contact CCPL

Patron Login

menu

Search Results

Your Filters

Engage with CCPL

Contact CCPL